Adaptimmune Therapeutics | ARS:年度報告
04/22 17:17 (美東)
Adaptimmune Therapeutics | 8-K:重大事件
04/12 08:07 (美東)
Adaptimmune Therapeutics | DEF 14A:股東委託書決議
04/11 08:04 (美東)
Adaptimmune Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-New Enterprise Associates 14, L.P.(6.7%),NEA Partners 14, L.P.(6.7%)等
04/02 20:41 (美東)
Adaptimmune Therapeutics | PRE 14A:並購重組委托聲明
04/01 08:06 (美東)
Adaptimmune Therapeutics | 3:首次持股聲明-股東 EcoR1 Capital, LLC
03/26 12:04 (美東)
Adaptimmune Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-EcoR1 Capital, LLC(10.7%),Oleg Nodelman(10.7%)等
03/26 12:04 (美東)
Adaptimmune Therapeutics | 4:持股變動聲明-高管 Piccina Cintia
03/18 17:01 (美東)
Adaptimmune Therapeutics | 10-K:年度報表
03/06 07:18 (美東)
Adaptimmune Therapeutics | 8-K:重大事件
03/06 07:08 (美東)
Adaptimmune Therapeutics | 8-K:重大事件
02/27 08:16 (美東)
Adaptimmune Therapeutics | 8-K:重大事件
02/16 16:10 (美東)
Adaptimmune Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Baker Bros. Advisors LP(4.8%),Baker Bros. Advisors (GP) LLC(4.8%)等
02/14 17:49 (美東)
Adaptimmune Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-LONG FOCUS CAPITAL MANAGEMENT, LLC(5.3%),JOHN B. HELMERS(5.3%)等
02/14 17:11 (美東)
Adaptimmune Therapeutics | 8-K:重大事件
01/31 17:13 (美東)
Adaptimmune Therapeutics | SC 13G:超過5%持股股東披露文件-EcoR1 Capital, LLC(7.7%),Oleg Nodelman(7.7%)等
01/30 17:29 (美東)
Adaptimmune Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Baillie Gifford & Co (Scottish partnership)(7.01%)
01/29 11:53 (美東)
Adaptimmune Therapeutics | 4:持股變動聲明-高管 Rawcliffe Adrian
01/17 00:00 (美東)
Adaptimmune Therapeutics | 4:持股變動聲明-高管 Bertrand William C JR
01/17 00:00 (美東)
Adaptimmune Therapeutics | 4:持股變動聲明-高管 Lunger John
01/17 00:00 (美東)
暫無數據
暫無數據